Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05074875 · ClinicalTrials.gov registry record
COVID-19 Respiratory Outcomes Registry
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 37
- Enrollment target
NCT05074875 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 37 participants.
The verdict
NCT05074875 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
Study Summary
This is a 48-week, observational study looking to see if the inflammatory process of hypoxemic respiratory failure associated with COVID-19 leads to progressive pulmonary fibrosis. Inpatient, as well as outpatient adults with recent COVID-19 hospitalization will be recruited. Data from hospitalization will be collected and subjects will return to the center for follow-up visits. Subjects will undergo the following procedures: High Resolution Computed Tomography (HRCT) of the chest, Pulmonary Function Tests (PFT), Muscle Strength Measurement, and blood draw for biomolecular data such as biomarkers found in ribonucleic acid (RNA), deoxyribonucleic acid (DNA), serum, and plasma. Quality of Life (QoL) measurements will also be collected through the study.
Interventions
- OTHER Questionnaires and Patient Reported Outcomes (PROs)
- DIAGNOSTIC_TEST Nasal Swab COVID-19 reverse transcription polymerase chain reaction test (RT-PCR)
- GENETIC Blood Samples for Biomarkers
- DIAGNOSTIC_TEST High Resolution Computed Tomography
- DIAGNOSTIC_TEST Physical Exam and Vital Signs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2021-01-15 |
| Est. Completion | 2023-05-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05074875
The ClinicalTrials.gov registry entry for NCT05074875 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Questionnaires and Patient Reported Outcomes (PROs) is the first listed.
NCT05074875 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05074875 about?
NCT05074875 is a clinical study titled "COVID-19 Respiratory Outcomes Registry". This is a 48-week, observational study looking to see if the inflammatory process of hypoxemic respiratory failure associated with COVID-19 leads to progressive pulmonary fibrosis. Inpatient, as well as outpatient adults with recent COVID-19 hospitalization will be recruited. Data from hospitalizati...
What is the current status of trial NCT05074875?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2021-01-15. Estimated completion is 2023-05-09.
What interventions are being tested in trial NCT05074875?
The interventions under investigation include: Questionnaires and Patient Reported Outcomes (PROs) (OTHER), Nasal Swab COVID-19 reverse transcription polymerase chain reaction test (RT-PCR) (DIAGNOSTIC_TEST), Blood Samples for Biomarkers (GENETIC), High Resolution Computed Tomography (DIAGNOSTIC_TEST), Physical Exam and Vital Signs (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05074875?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.